Endothelial dysfunction and hypertension in obstructive sleep apnea - Is it due to intermittent hypoxia?

Journal of Cardiovascular Disease Research

Volumn 4, Issue 2, 2013, Pages 87-91

  Jafari, Behrouz ^a   Mohsenin, Vahid ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHN B PIERCE LABORATORY   (United States)

Author keywords

Angiogenesis inhibitors; Endothelial dysfunction; Hypertension; Sleep apnea

Indexed keywords

ENDOGLIN; FMS LIKE TYROSINE KINASE 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; APNEA HYPOPNEA INDEX; ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXYGEN DESATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING; SLEEP TIME; VASODILATATION;

EID: 84880514100     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.1016/j.jcdr.2013.04.001     Document Type: Article

References (37)

1. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 328 1993 1230 1235
2. L.F. Drager, L.A. Bortolotto, M.C. Lorenzi, A.C. Figueiredo, E.M. Krieger, and G. Lorenzi-Filho Early signs of atherosclerosis in obstructive sleep apnea Am J Respir Crit Care Med 172 2005 613 618
3. N.A. Shah, H.K. Yaggi, J. Concato, and V. Mohsenin Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death Sleep Breath 14 2010 131 136
4. H.K. Yaggi, J. Concato, W.N. Kernan, J.H. Lichtman, L.M. Brass, and V. Mohsenin Obstructive sleep apnea as a risk factor for stroke and death N Engl J Med 353 2005 2034 2041
5. P.E. Peppard, T. Young, M. Palta, and J. Skatrud Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 342 2000 1378 1384
6. V. Mohsenin, H.K. Yaggi, N. Shah, and J. Dziura The effect of gender on the prevalence of hypertension in obstructive sleep apnea Sleep Med 10 2009 759 762
7. F.J. Nieto, T.B. Young, and B.K. Lind Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 283 2000 1829 1836
8. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
9. S.M. Wallace, Yasmin, and C.M. McEniery Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction Hypertension 50 2007 228 233
10. J. Dallongeville, L. Tiret, and S. Visvikis Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study Atherosclerosis 145 1999 381 388
11. R. Rossi, E. Chiurlia, A. Nuzzo, E. Cioni, G. Origliani, and M.G. Modena Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women J Am Coll Cardiol 44 2004 1636 1640
12. M.S. Ip, H.F. Tse, B. Lam, K.W. Tsang, and W.K. Lam Endothelial function in obstructive sleep apnea and response to treatment Am J Respir Crit Care Med 169 2004 348 353
13. M. Grebe, H.J. Eisele, and N. Weissmann Antioxidant vitamin C improves endothelial function in obstructive sleep apnea Am J Respir Crit Care Med 173 2006 897 901
14. S. Jelic, M. Padeletti, and S.M. Kawut Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea Circulation 117 2008 2270 2278
15. A. Atkeson, S.Y. Yeh, A. Malhotra, and S. Jelic Endothelial function in obstructive sleep apnea Prog Cardiovasc Dis 51 2009 351 362
16. L.F. Drager, L.A. Bortolotto, E.M. Krieger, and G. Lorenzi-Filho Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis Hypertension 53 2009 64 69
17. V. Mohsenin, and F. Urbano Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension Respir Med 105 2011 801 807
18. C.W. Redman, and I.L. Sargent Placental stress and pre-eclampsia: a revised view Placenta 30 suppl A 2009 S38 S42
19. T. Sanchez-Elsner, L.M. Botella, B. Velasco, C. Langa, and C. Bernabeu Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways J Biol Chem 277 2002 43799 43808
20. J.M. Foidart, J.P. Schaaps, F. Chantraine, C. Munaut, and S. Lorquet Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia - a step forward but not the definitive answer J Reprod Immunol 82 2009 106 111
21. G.S. Di Marco, S. Reuter, and U. Hillebrand The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD J Am Soc Nephrol 20 2009 2235 2245
22. K. Onoue, S. Uemura, and Y. Takeda Usefulness of soluble fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction Am J Cardiol 104 2009 1478 1483
23. S.A. Karumanchi, and I.E. Stillman In vivo rat model of preeclampsia Methods Mol Med 122 2006 393 399
24. F. Lu, M. Longo, and E. Tamayo The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice Am J Obstet Gynecol 196 2007 396 e391-e397 http://dx.doi.org/10.1016/j.ajog.2006.12.024 Accessed 31.12.12
25. B. Jafari, and V. Mohsenin Activation of heme oxygenase and suppression of cGMP are associated with impaired endothelial function in obstructive sleep apnea with hypertension Am J Hypertens 25 2012 854 861
26. M.H. Alderman JNC 7: brief summary and critique Clin Exp Hypertens 26 2004 753 761
27. K.S. Heffernan, J.T. Kuvin, A.R. Patel, R.H. Karas, and N.K. Kapur Endothelial function and soluble endoglin in smokers with heart failure Clin Cardiol 34 2011 729 733
28. H.A. Chami, M.J. Keyes, and J.A. Vita Brachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing Vasc Med 14 2009 351 360
29. A.M. Blazquez-Medela, L. Garcia-Ortiz, and M.A. Gomez-Marcos Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients BMC Med 8 2010 86 97
30. T. Ikemoto, Y. Hojo, and H. Kondo Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases Heart Vessels 27 2012 344 351
31. D.S. Moller, P. Lind, B. Strunge, and E.B. Pedersen Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea Am J Hypertens 16 2003 274 280
32. M. Pons, S.W. Cousins, O. Alcazar, G.E. Striker, and M.E. Marin-Castano Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration Am J Pathol 2011 2665 2681
33. L.M. Botella, T. Sanchez-Elsner, and F. Sanz-Rodriguez Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood 100 2002 4001 4010
34. E. Torsney, R. Charlton, D. Parums, M. Collis, and H.M. Arthur Inducible expression of human endoglin during inflammation and wound healing in vivo Inflamm Res 51 2002 464 470
35. B. Wang, B. Yan, D. Song, X. Ye, and S.F. Liu Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-kappaB-dependent mechanism Sleep Med 2012 http://dx.doi.org/10.1016/j.sleep. 2012.10.020 Accessed 31.12.12
36. T.E. Walshe, V.S. Dole, A.S. Maharaj, I.S. Patten, D.D. Wagner, and P.A. D'Amore Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling Arterioscler Thromb Vasc Biol 29 2009 1185 1192
37. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683